GoodRx Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
GDRX$3.65+4.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands, except per share amounts) | 2024 | 2023 | 2022 |
| Revenue | $792,324 | $750,265 | $766,554 |
| Costs and operating expenses: | |||
| Cost of revenue, exclusive of depreciation and amortization presented separately below | 48,215 | 66,925 | 65,079 |
| Product development and technology | 123,749 | 135,836 | 143,137 |
| Sales and marketing | 367,114 | 341,328 | 357,631 |
| General and administrative | 117,862 | 125,515 | 144,792 |
| Depreciation and amortization | 69,538 | 107,668 | 54,177 |
| Total costs and operating expenses | 726,478 | 777,272 | 764,816 |
| Operating income (loss) | 65,846 | (27,007) | 1,738 |
| Other expense, net: | |||
| Other expense | (2,660) | (4,008) | — |
| Loss on extinguishment of debt | (2,077) | — | — |
| Interest income | 23,273 | 32,171 | 9,274 |
| Interest expense | (52,922) | (56,728) | (34,243) |
| Total other expense, net | (34,386) | (28,565) | (24,969) |
| Income (loss) before income taxes | 31,460 | (55,572) | (23,231) |
| Income tax (expense) benefit | (15,070) | 46,704 | (9,597) |
| Net income (loss) | $16,390 | $(8,868) | $(32,828) |
| Earnings (loss) per share: | |||
| Basic | $0.04 | $(0.02) | $(0.08) |
| Diluted | $0.04 | $(0.02) | $(0.08) |
| Weighted average shares used in computing earnings (loss) per share: | |||
| Basic | 385,737 | 410,315 | 412,858 |
| Diluted | 392,172 | 410,315 | 412,858 |
| Stock-based compensation included in costs and operating expenses: | |||
| Cost of revenue | $320 | $610 | $359 |
| Product development and technology | 24,649 | 30,096 | 35,190 |
| Sales and marketing | 33,374 | 20,311 | 21,036 |
| General and administrative | 40,683 | 53,803 | 63,649 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.